Stephen K. Gruschkus, Ph.D.
Affiliations: | 2009 | Epidemiology & Disease Control | The University of Texas School of Public Health |
Area:
EpidemiologyGoogle:
"Stephen Gruschkus"Parents
Sign in to add mentor| Xianglin L. Du | grad student | 2009 | The University of Texas School of Public Health | |
| (Clinical outcomes and cost-effectiveness of white blood cell growth factors in elderly patients with non -Hodgkin's lymphoma: Findings from a large population-based cohort.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ballhausen A, Urias E, Gruschkus SK, et al. (2021) Metastatic Risk Factors Associated with Class 1A Uveal Melanoma Patients. Cancers. 13 |
| Nieto Y, Gruschkus S, Valdez BC, et al. (2021) Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis. Haematologica |
| Shah M, Winfree KB, Peterson P, et al. (2013) Cost effectiveness of first-line pemetrexed plus platinum compared with other regimens in the treatment of patients with nonsquamous non-small cell lung cancer in the US outpatient setting. Lung Cancer (Amsterdam, Netherlands). 82: 121-7 |
| Nadler E, Yu E, Ravelo A, et al. (2011) Bevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice network. The Oncologist. 16: 486-96 |
| Gruschkus SK, Lairson D, Dunn JK, et al. (2011) Cost-effectiveness of white blood cell growth factor use among a large nationwide cohort of elderly non-Hodgkin's lymphoma patients treated with chemotherapy. Value in Health : the Journal of the International Society For Pharmacoeconomics and Outcomes Research. 14: 253-62 |
| Gruschkus SK, Lairson D, Dunn JK, et al. (2010) Comparative effectiveness of white blood cell growth factors on neutropenia, infection, and survival in older people with non-Hodgkin's lymphoma treated with chemotherapy. Journal of the American Geriatrics Society. 58: 1885-95 |
| Gruschkus SK, Lairson D, Dunn JK, et al. (2010) Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly patients with non-Hodgkin lymphoma. Cancer. 116: 5279-89 |
| Gruschkus SK, Lairson DR, Dunn JK, et al. (2010) Abstract B129: Use of white blood cell growth factors and risk of acute myeloid leukemia or myelodysplastic syndrome among elderly non‐Hodgkin's lymphoma patients Cancer Prevention Research. 3 |
| Gruschkus S, Lairson D, Dunn J, et al. (2010) PCN76 COST-EFFECTIVENESS OF WHITE BLOOD CELL GROWTH FACTOR USE AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS TREATED WITH CHEMOTHERAPY Value in Health. 13: A38 |
| Gruschkus S, Lairson D, Dunn J, et al. (2010) PCN1 USE OF WHITE BLOOD CELL GROWTH FACTORS AND RISK OF ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROMES AMONG ELDERLY NON-HODGKIN'S LYMPHOMA PATIENTS Value in Health. 13: A23 |